Pesquisar
LivaNova PLC
LIVNAdicionar à lista de desejos
71.740USD
+1.650+2.35%
Fechamento 05/12, 16:00（ET）Cotações atrasadas em 15 min
3.92BValor de mercado
36.28P/L TTM
Mais detalhes de LivaNova PLC Empresa
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Informações de LivaNova PLC
Código da empresaLIVN
Nome da EmpresaLivaNova PLC
Data de listagemOct 19, 2015
CEOMakatsaria (Vladimir A)
Número de funcionários2900
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 19
Endereço20 Eastbourne Terrace
CidadeLONDON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited Kingdom
Código postalW2 6LG
Telefone442033250662
Sitehttps://www.livanova.com/
Código da empresaLIVN
Data de listagemOct 19, 2015
CEOMakatsaria (Vladimir A)
Executivos da empresa LivaNova PLC
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
44.65K
--
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
22.19K
+42.53%
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
--
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
10.97K
+17.36%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
--
Mr. Francesco Bianchi
Mr. Francesco Bianchi
Independent Director
Independent Director
9.03K
--
Mr. Michael Damon Hutchinson
Mr. Michael Damon Hutchinson
Senior Vice President, Chief Legal Officer, Company Secretary
Senior Vice President, Chief Legal Officer, Company Secretary
6.80K
--
Ms. Brooke Story
Ms. Brooke Story
Independent Director
Independent Director
6.23K
--
Ahmet Tezel
Ahmet Tezel
Senior Vice President, Chief Innovation Officer
Senior Vice President, Chief Innovation Officer
4.16K
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
44.65K
--
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
22.19K
+42.53%
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
--
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
10.97K
+17.36%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
739.57M
53.28%
Rest of World
379.30M
27.33%
Europe
269.18M
19.39%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.63%
PRIMECAP Management Company
7.69%
Millennium Management LLC
4.44%
Artisan Partners Limited Partnership
4.21%
AQR Capital Management, LLC
3.92%
Outro
68.10%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.63%
PRIMECAP Management Company
7.69%
Millennium Management LLC
4.44%
Artisan Partners Limited Partnership
4.21%
AQR Capital Management, LLC
3.92%
Outro
68.10%
Tipos de investidores
Investidores
Proporção
Investment Advisor
52.81%
Investment Advisor/Hedge Fund
32.62%
Hedge Fund
13.88%
Research Firm
2.81%
Pension Fund
2.25%
Bank and Trust
1.55%
Individual Investor
0.37%
Sovereign Wealth Fund
0.05%
Family Office
0.04%
Participação acionária institucional
Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
609
60.49M
110.12%
-11.26M
2025Q4
575
58.07M
106.34%
-10.58M
2025Q3
562
56.86M
104.13%
-8.50M
2025Q2
564
56.85M
104.11%
-6.95M
2025Q1
581
56.61M
103.82%
-8.04M
2024Q4
586
56.98M
104.84%
-8.56M
2024Q3
563
55.15M
101.56%
-9.48M
2024Q2
546
57.21M
105.64%
-8.52M
2024Q1
547
58.00M
107.51%
-6.90M
2023Q4
532
56.62M
105.11%
-7.28M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
6.39M
11.68%
+51.59K
+0.81%
Dec 31, 2025
PRIMECAP Management Company
4.22M
7.73%
-219.98K
-4.95%
Dec 31, 2025
Millennium Management LLC
3.48M
6.37%
+514.27K
+17.32%
Dec 31, 2025
Artisan Partners Limited Partnership
2.32M
4.23%
-111.72K
-4.60%
Dec 31, 2025
AQR Capital Management, LLC
2.16M
3.94%
+496.17K
+29.91%
Dec 31, 2025
Wellington Management Company, LLP
2.02M
3.69%
-328.86K
-14.02%
Dec 31, 2025
State Street Investment Management (US)
2.01M
3.68%
-43.95K
-2.14%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
1.79M
3.27%
+66.75K
+3.88%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.46M
2.67%
+12.75K
+0.88%
Dec 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
State Street SPDR S&P Health Care Equipment ETF
1.66%
JPMorgan Active Small Cap Value ETF
1.43%
Invesco NASDAQ Future Gen 200 ETF
0.5%
Simplify Health Care ETF
0.43%
Global X Aging Population ETF
0.42%
JPMorgan Fundamental Data Science Small Core ETF
0.37%
Avantis US Small Cap Equity ETF
0.34%
iShares U.S. Medical Devices ETF
0.34%
WisdomTree US SmallCap Fund
0.33%
Federated Hermes MDT Small Cap Core ETF
0.33%
Ver Mais
State Street SPDR S&P Health Care Equipment ETF
Proporção1.66%
JPMorgan Active Small Cap Value ETF
Proporção1.43%
Invesco NASDAQ Future Gen 200 ETF
Proporção0.5%
Simplify Health Care ETF
Proporção0.43%
Global X Aging Population ETF
Proporção0.42%
JPMorgan Fundamental Data Science Small Core ETF
Proporção0.37%
Avantis US Small Cap Equity ETF
Proporção0.34%
iShares U.S. Medical Devices ETF
Proporção0.34%
WisdomTree US SmallCap Fund
Proporção0.33%
Federated Hermes MDT Small Cap Core ETF
Proporção0.33%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
